Supplier profile
Pierre Fabre Pharma GmbH
Every public-sector award we hold for this supplier, across Germany, from 1 Aug 2023 to 10 Sept 2024.
Awards won
14
all time
Attributed value
€93k
13 shared, unvalued
Buyers
3
public bodies
Active
2023–2024
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 9 | not attributable |
| IKK classic | 3 | €93k |
| GWQ ServicePlus AG | 2 | not attributable |
What they win
Awards
All 14 awards we hold
- 101 - DAK / KKH - Colecalciferol - A11CC05 (TEI) ↗DAK-Gesundheitshared awardawarded 10 Sept 2024
- Germany – Pharmaceutical products – Generika-Ersatzkassen 20 ↗DAK-Gesundheitshared awardawarded 31 Aug 2024
- Germany – Pharmaceutical products – post_Arzneimittelausschreibung_2024 b ↗IKK classicshared awardawarded 27 Jul 2024
- 131 | Mesalazin Tabletten magensaftresistent [1] ↗IKK classic€93kawarded 26 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (1b) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Levetiracetam (FTA) ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Propranolol (ausschließlich LSE), ATC C07AA05 für die Zeit 01.07.2024 - 30.06.2026 ↗DAK-Gesundheitshared awardawarded 2 Jul 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobetasol, ATC D07AD01 für die Zeit 01.12.2023 - 30.11.2025 ↗DAK-Gesundheitshared awardawarded 1 Dec 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobetasol, ATC D07AD01 für die Zeit 01.12.2023 - 30.11.2025 ↗DAK-Gesundheitshared awardawarded 1 Dec 2023
- Germany-Dresden: Pharmaceutical products ↗IKK classicshared awardawarded 5 Sept 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Vinorelbin (ausschließlich orale Darreichungsformen), ATC L01CA04 für die Zeit 01.09.2023 - 31.08.2025 ↗DAK-Gesundheitshared awardawarded 2 Sept 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Vinorelbin (ausschließlich orale Darreichungsformen), ATC L01CA04 für die Zeit 01.09.2023 - 31.08.2025 ↗DAK-Gesundheitshared awardawarded 1 Sept 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fluorouracil, ATC D11AF05 für die Zeit 01.08.2023 - 31.07.2025 ↗DAK-Gesundheitshared awardawarded 2 Aug 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fluorouracil, ATC D11AF05 für die Zeit 01.08.2023 - 31.07.2025 ↗DAK-Gesundheitshared awardawarded 1 Aug 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.